Results 191 to 200 of about 12,173,418 (313)

Spatial Proteomics Identifies Distinct Synovial Microenvironments in Hip and Knee Osteoarthritis

Arthritis &Rheumatology, Accepted Article.
Objective Osteoarthritis (OA) is a heterogeneous joint disease, yet mechanistic insights derive predominantly from knee OA and are often extrapolated to other joints. We investigated joint‐associated differences in the spatial molecular organization of hip and knee OA synovium.
Peng Xie, Antonia R. Sun, Zhengtan Zheng, Yunkun Qu, Feng Gao, Christina Theodoropoulos, Nicholas Matigian, Zhiyong Li, Ross Crawford, Indira Prasadam   +9 more
wiley   +1 more source

Placebo effect on brainstem activity associated with capsaicin-evoked urge to cough in healthy humans. [PDF]

Eur Respir J
Moe AAK, Bautista TG, Leech J, Mazzone SB, Farrell MJ.   +4 more
europepmc   +1 more source

n-3 PUFAs for depression: treatment effect or absence-of-placebo effect? [PDF]

Transl Psychiatry, 2022
Memarpouri A, van der Does W, Molendijk ML.   +2 more
europepmc   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source

The Power of Belief: Investigating the Placebo Effect in Post-Exercise Recovery Strategies for Football Players. [PDF]

Healthcare (Basel)
Pernigoni M, Alfieri AO, Kniubaitė A, Kamandulis S, Conte D, Lukonaitienė I.   +5 more
europepmc   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

The Placebo Effect of Insider Dealing Regulation. [PDF]

Oxf J Leg Stud
Enriques L, Alex Lee YH, Romano A.
europepmc   +1 more source

PLACEBO EFFECT AND SPORT: AN ANALYSIS OF THE MECHANISM, EVIDENCE AND IMPACT ON PHYSICAL PERFORMANCE

reservedIn questo elaborato, dopo aver ripreso le classiche definizioni di placebo e aver percorso la sua storia, viene indagato il suo funzionamento a livello neurobiologico e l’influenza di aspettative e apprendimento sulla sua buona riuscita, andando ...
CORBETTA, GIACOMO
core  

Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience

British Journal of Clinical Pharmacology, EarlyView.
Problem setting The emergence of therapeutic proteins has coincided with an increase of acute adverse immunostimulation (AIS). AIS has occured in clinical trials despite compliance with regulatory guidelines on preclinical evaluation and its incidence is anticipated to increase even further.
Juliette A. van den Noort, Marella C. E. van Ruissen, Lisanne C. A. Smidt, Naomi B. Klarenbeek, Philip H. K. Kremer, Manon A. A. Jansen, Jacobus Burggraaf, Joop M. A. van Gerven, Matthijs Moerland   +8 more
wiley   +1 more source

Motor placebo effect in obesity: how ergogenic aids can decrease fatigue and improve motor performance. [PDF]

Eat Weight Disord
Volpino V, Navarra ME, Scarpina F, Piedimonte A, Scacchi M, Bianchi L, Mauro A, Carlino E.   +7 more
europepmc   +1 more source